Selcaxen 40 Mg (Selpercatinib) – 30 Capsules

Selcaxen 40 Mg (Selpercatinib) is an advanced oral therapy specifically designed for the treatment of cancers with rearranged during transfection (RET) gene fusions or mutations. Containing Selpercatinib, Selcaxen 40 mg is a selective RET kinase inhibitor that targets RET-driven tumors, offering an effective treatment option for patients with RET fusion-positive non-small cell lung cancer (NSCLC) and thyroid cancers.

Selcaxen 40 mg is indicated for the treatment of:

• RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC): Selcaxen 40 is used in adult patients with metastatic RET fusion-positive NSCLC who require systemic therapy, particularly those who have progressed on or are intolerant to other treatments.
• RET-Altered Thyroid Cancer: Selcaxen is also indicated for the treatment of patients with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer who require systemic therapy.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Selcaxen 40 Mg (Selpercatinib) medicine.